Summary
The chemical breakdown of carmethizole [1-methyl-2-methylthio-4,5-bis-(hydroxymethyl)imidazole-4′,5′-bis(N-methylcarbamate)hydrochloride] and its pharmacokinetics in the mouse and beagle dog were studied. Carmethizole was relatively unstable in aqueous media, having a half-life of ≤1 h in 0.9% sodium chloride, human whole blood, human plasma, and dog urine at 37°C. Its major breakdown product in 0.9% sodium chloride and pH 5.0 sodium phosphate buffer was carmethizole diol. When carmethizole was added to pH 7.0 or pH 9.0 sodium phosphate buffer, the major breakdown product was carmethizole diol-4′-monophosphate. Carmethizole reacted directly with glutathione at pH 8.0, forming a glutathione adduct of carmethizole monocarbamate. Elimination of the drug from the plasma of the beagle dog following i.v. bolus doses of 22.4 and 4.3 mg/kg was biphasic. At these doses the terminal half-life was 39 and 46 min, respectively, and the respective total body clearance was 4.6 and 7.7 ml/min per kg. The 22.4 mg/kg dose was lethal to the beagle dog by day 4. Elimination of carmethizole from the plasma of mice following an i. v. bolus dose of 115 mg/kg was monoexponential, with a half-life of 11.6 min and a total body plasma clearance of 43.6 ml/min per kg. When the drug was infused at 230 mg/kg over 8 h into mice, the total body clearance was 40.8 ml/min per kg. Following the i.v. bolus administration of carmethizole to mice, 30% of the total dose was excreted in urine over 3 h as carmethizole diol, 10%, as carmethizole diol-sulfate, 3.4%, as carmethizole 4′-monocarbamate, and 2.4%, as unchanged drug.
Similar content being viewed by others
References
Anderson WK, Bhattacharjee D, Houston DM (1988) Design, synthesis, antineoplastic activity, and chemical properties of bis-carbamate derivatives of 4,5-bis (hydroxymethyl)imidazole. J Med Chem (in press)
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248
Cohen GM, Haws SM, Moore BP, Bridges JW (1976) Benzo(a)pyrene-3-yl hydrogen sulphate, a major ethyl acetate-extractable metabolite of benzo(a)pyrene in human, hamster and rat lung cultures. Biochem Pharmacol 25:2561
Ernster L, Siekevitz P, Palade PE (1962) Enzyme-structure relationshipss of the endoplasmic reticulum of rat liver. J Cell Biol 15:541
Marchard DH, Remmel RP, Abdel-Monem MM (1988) Biliary excretion of glutathione conjugate of busulfan and 1,4-diiodobutane in the rat. Drug Metab Dispos 16:85
Metzler CM, Elfring G, McEwen AJ (1974) A package of computer programs for pharmacokinetic modeling. Biometrics 30:562
National Cancer Institute Preclinical Brochure (1987) Anderson (NSC 602668). National Cancer Institute, Bethesda, Md
Tomasz M, Lipman R (1979) Alkylation reactions of mitomycin C at acid pH. J Am Chem Soc 101:6063
Tomasz M, Lipman R (1981) Reductive metabolism and alkylating activity of mitomycin C induced by rat liver microsomes. Biochemistry 20:5056
Wagner JG (1976) Pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data. J Pharmacokinet Biopharm 4:443
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brodfuehrer, J.I., Wilke, T.J., Kinder, D.H. et al. Preclinical pharmacologic studies of the new antitumor agent carmethizole (NSC-602668) in the mouse and beagle dog. Cancer Chemother. Pharmacol. 24, 277–283 (1989). https://doi.org/10.1007/BF00304758
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00304758